Looking Beyond Linear: How Pharma Marketers Can Capitalize on Connected TV 2022

Streaming is having a moment in the sun, and of course, advertisers are right there basking in its glow. We’ve seen a huge uptick in clients running connected TV (CTV) campaigns on our platform, and as healthcare advertisers increasingly embrace this exciting channel, we’re here to help them capitalize on its incredible value.

We’ve written our latest whitepaper, Looking Beyond Linear: How Pharma Marketers Can Capitalize on Connected TV in 2022, along with a diverse group of strategic partners that includes LG Ads Solutions, Matterkind, FreeWheel, LiveRamp, Tubi, and the Video Advertising Bureau (VAB).

Download the whitepaper to see the campaign data behind our CTV success stories, and read predictions from our leadership and partners.

Share this Post

Related Articles

 In this bonus episode of Deep: The Healthcare Marketing Podcast, host John Mangano sits down with DeepIntent Founder and CEO Chris Paquette for a candid, wide-ranging conversation on the future of healthcare marketing—and what it means to get it right. Chris shares the story of how his unique background led to the creation of DeepIntent. He […]

What’s the secret to improving your reach, optimizing campaign performance, and driving better health outcomes for consumers today? It’s simple: Health IntelligenceTM. By combining real-time data, artificial intelligence (AI), and programmatic advertising, Health Intelligent campaigns deliver more personalized and relevant health engagements with unmatched speed. As we enter a new era of healthcare advertising, Health […]

 In Episode 9, host John Mangano sits down with Dr. Brad Bowman, MD, Chief Medical Officer and Head of Data Science and Quality at Healthgrades. Brad offers a unique perspective on the intersection of healthcare and artificial intelligence (AI). You may know that AI is already transforming medicine, from reading X-rays to predicting health […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.